Comparison of effect of Dexmedetomidine and Remifentanil added to Thiopental for hemodynamic responses and seizure time in mood disorder patients who are candidate for ECT

Phase 2

Recruiting

• Conditions: Mood disorder.; Mood disorder due to known physiological condition

• Registration Number: IRCT20141209020258N90
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

All patients with mood disorder candidate electroshock
18-55 years old

Exclusion Criteria

having renal, liver, heart and lung diseases
patients who have been in addition to psychotic mood disorders
contraindication for ECT
patients with head injuries
patients with head injuries, patients who do not seizure after taking ECT
patients requiring intubation after ECT due to respiratory impairment and long-term apnea

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Before, in the recovery and after the ECT. Method of measurement: Barometer.;Heart rate. Timepoint: Before, in the recovery and after the ECT. Method of measurement: Kronometer.;Seizure duration. Timepoint: Duration ECT. Method of measurement: Kronometer.;Duration recovery. Timepoint: Duration in recovery. Method of measurement: Kronometer.;Agitation. Timepoint: Before, in the recovery and after the ECT. Method of measurement: Physical examination.;Satisfaction. Timepoint: In the recovery and after the ECT. Method of measurement: Physical examination.